Preliminary Pharmacokinetics (Pk), Safety And Efficacy Of Two Dosing Regimens Of Cs1003 (Anti-Pd-1) In Solid Tumours: 200 Mg Every 3-Week (Q3w) And 400 Mg Every 6-Week (Q6w) Dosing

B. Markman, D. Day, J. J. W. Park,J. Coward,S. Bishnoi,D. Kotasek, R. Eek,M. P. Brown,C. Lemech, J. Kuo, A. Prawira, R. Strother,Q. Zhang,L. Wang,R. Chen,Y. Ma,Z. Qin,A. Tse

Annals of Oncology(2020)

引用 0|浏览59
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要